The benefit of combination therapy depends on disease phenotype and duration in Crohn’s disease

INTRODUCTION: The impact of combination therapy on disease-related morbidity in patients with established Crohn’s disease (CD) or ulcerative colitis (UC) remains to be well-defined. AIM: To examine the effect of combination therapy on disease outcomes in CD and UC METHODS: Using a multi-center prosp...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Aliment Pharmacol Ther
Hlavní autoři: Ananthakrishnan, Ashwin N, Sakuraba, Atsushi, Barnes, Edward L, Pekow, Joel, Raffals, Laura, Long, Millie D, Sandler, Robert S
Médium: Artigo
Jazyk:Inglês
Vydáno: 2017
Témata:
Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC5484085/
https://ncbi.nlm.nih.gov/pubmed/28470787
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/apt.14125
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky